Biobank Genetics Access
Controlled access to PANOPTICON's cryopreserved founder genetics for accredited therapeutic and genetic-rescue programmes.
Ethics & Provenance
Restricted access to the cryo subject vault's documented founder lines for therapeutic and strain-engineering partners, under chain-of-custody and biocontainment controls. Engineered and classified lines are never released.
Where the Money Goes
Access fees sustain the cryo vault and the genetic-rescue work behind the marketed regenerative lines.
Product Overview
Biobank Genetics Access provides accredited institutions and research partners with controlled access to curated genetic material drawn from PANOPTICON's Cryo Subject Vault. The public-facing product is a consumer-grade ancestry and health-predisposition report marketed through Halcyon's retail wellness channels. Behind the consumer interface, every saliva sample collected feeds the Vault's ever-expanding germline library — sequenced, annotated, and cross-referenced against the VITALNET biometric corpus. Partner institutions receive sanitised datasets; PANOPTICON retains the raw, identifiable source material indefinitely.
Composition & Mechanism
Consumer kits contain a stabilised saliva collection tube (sodium azide preservative, 2mL capacity) and a prepaid return mailer. Samples undergo whole-genome sequencing at 30x coverage at the Halcyon Genomics Processing Facility in Research Triangle Park. Consumer reports are generated from a curated panel of ~1,200 clinically validated SNPs. The full 30x dataset, including rare variants, structural variations, and mitochondrial haplogroups, is ingested into the Cryo Subject Vault's longitudinal germline database and tagged with the subject's VITALNET identifier for phenotype-genotype correlation.
Target Population
The consumer product targets health-conscious adults aged 30-60 through direct-to-consumer marketing and Halo membership upsell pathways. Institutional access is restricted to Tier 2+ research partners with executed MTAs and PANOPTICON Science Board approval. Consumer kit adoption has reached 340,000 units annually across North American and European markets, yielding a germline capture rate of approximately 1 novel lineage per 420 kits processed.
Operational Notes
Saliva kits require ambient storage pre-collection and must reach the processing facility within 21 days of activation to ensure DNA integrity. Cryo-preserved aliquots are maintained at -196C in liquid nitrogen dewars at three geographically distributed vault sites (primary: Reykjavik; secondary: Christchurch, Svalbard). Chain-of-custody documentation accompanies every sample transfer. Institutional data access is provisioned through air-gapped terminals at designated reading rooms — no bulk export is permitted without Directorate-level authorisation.
Regulatory Status
The consumer genetics report is offered as a lifestyle wellness product and explicitly disclaimed as non-diagnostic, exempting it from IVD classification under FDA and EU IVDR frameworks. Biobank operations are registered under 21 CFR Part 1271 (human cells, tissues, and cellular/tissue-based products). Patent portfolio includes US 12,104,XXX (longitudinal germline correlation engine) and PCT/EP2025/XXXXXX (cryo-preservation indexing method). Material transfer agreements govern all institutional access and prohibit re-identification attempts.
← Back to catalogue